“Bioconjugates of Melanostatin and Amantadine: Positive Allosteric Modulation of Human Dopamine D2 Receptors with Mild Toxicity at High Concentrations”

https://pubmed.ncbi.nlm.nih.gov/38116429

Scientists have created and tested bioconjugates of melanostatin and amantadine that positively allosterically modulate human dopamine D2 receptors, with some showing mild toxicity at high concentrations.